InvestorsHub Logo
Followers 7
Posts 889
Boards Moderated 0
Alias Born 06/15/2015

Re: jondoeuk post# 41

Sunday, 04/09/2023 9:10:54 AM

Sunday, April 09, 2023 9:10:54 AM

Post# of 46
Don't need to convince us. We are fully invested and believers in both the INKmune NK cell therapy for certain cancers as well as XPro for AD and possibly others neuro inflammation sensitive diseases, including Parkinson’s.

Two robust programs and each have multi-billion value potential based on TAM

Exciting times.

GLTA longs
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INMB News